Literature DB >> 20695749

Congenital transmission of Chagas disease: a clinical approach.

Inés Oliveira1, Faustino Torrico, Jose Muñoz, Joaquim Gascon.   

Abstract

Chagas disease is caused by the protozoan Trypanosoma cruzi and is an endemic zoonosis in the American continent. Thanks to the successful implementation of national programs for reducing the vectorial infestation and the strict control of blood-borne transmission of Chagas disease, the relative importance of congenital transmission has recently increased. Nowadays, in areas without vectorial transmission, congenital transmission has become the main way by which the disease has spread. This article reviews current knowledge on Chagas disease, focusing on the congenital transmission route. The public health implications of the increasing number of T. cruzi-infected immigrants and congenital transmission in nonendemic areas is also analyzed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20695749     DOI: 10.1586/eri.10.74

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  24 in total

1.  Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment.

Authors:  José A Pérez-Molina; Francesca Norman; Rogelio López-Vélez
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

Review 2.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

3.  Trypanosoma cruzi experimental congenital transmission associated with TcV and TcI subpatent maternal parasitemia.

Authors:  Sandra Maria Alkmim-Oliveira; André Guilherme Costa-Martins; Henrique Borges Kappel; Dalmo Correia; Luis Eduardo Ramirez; Eliane Lages-Silva
Journal:  Parasitol Res       Date:  2012-11-18       Impact factor: 2.289

4.  Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.

Authors:  Africa Holguín; Francesca Norman; Leticia Martín; María Luisa Mateos; Jesús Chacón; Rogelio López-Vélez; José A Pérez-Molina
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

Review 5.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 6.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

7.  Towards a New Strategy for Diagnosis of Congenital Trypanosoma cruzi Infection.

Authors:  Alba Abras; Carmen Muñoz; Cristina Ballart; Pere Berenguer; Teresa Llovet; Mercedes Herrero; Silvia Tebar; María-Jesús Pinazo; Elizabeth Posada; Carmen Martí; Victoria Fumadó; Jordi Bosch; Oriol Coll; Teresa Juncosa; Gemma Ginovart; Josep Armengol; Joaquim Gascón; Montserrat Portús; Montserrat Gállego
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

8.  Prevalence and risk factors for Chagas disease in pregnant women in Casanare, Colombia.

Authors:  Zulma M Cucunubá; Astrid C Flórez; Angela Cárdenas; Paula Pavía; Marleny Montilla; Rodrigo Aldana; Katherine Villamizar; Lyda C Ríos; Rubén S Nicholls; Concepción J Puerta
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

9.  Benznidazole Extended-Release Tablets for Improved Treatment of Chagas Disease: Preclinical Pharmacokinetic Study.

Authors:  Marcelo Gomes Davanço; Michel Leandro Campos; Talita Atanazio Rosa; Elias Carvalho Padilha; Alejandro Henao Alzate; Larissa Araújo Rolim; Pedro José Rolim-Neto; Rosângela Gonçalves Peccinini
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

10.  Trypomastigote Excretory Secretory Antigen Blot Is Associated With Trypanosoma cruzi Load and Detects Congenital T. cruzi Infection in Neonates, Using Anti-Shed Acute Phase Antigen Immunoglobulin M.

Authors:  Sassan Noazin; Jessica A Lee; Edith S Malaga; Edward Valencia Ayala; Beth J Condori; Cristian Roca; Andres G Lescano; Caryn Bern; Walter Castillo; Holger Mayta; Maria Carmen Menduiña; Manuela R Verastegui; Freddy Tinajeros; Robert H Gilman
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.